Santos, Railson de Sousa, Nunes, Paulo Humberto Moreira, Lima, Geovanni de Morais, Brito, Ana Karolinne da Silva, Pacheco, James Frederico Rocha, Medina, Heldemys da Costa, Benigno, Maria Ivone Mendes, Sousa, Damião Pergentino de, Moura-Filho, Oseas Florêncio de, Cunha, Francisco Valmor Macedo, Reis, Renandro de Carvalho, Oliveira, Rita de Cássia Meneses, Arcanjo, Daniel Dias Rufino, and Martins, Maria do Carmo de Carvalho e
The acute toxicity and hypokinetic activity induced by menthofuran on the gastrointestinal tract of rodents were investigated in the present study. An absence of acute toxicity was observed. Menthofuran delayed gastric emptying at oral doses of 25, 50, and 100 mg/kg in the experimental model of phenol red, as well as it reduced the intestinal transit at oral doses of 50 and 100 mg/kg. Interestingly, a scopolamine-similar hypokinetic effect was observed for menthofuran. In the experimental model of castor oil-induced intestinal hypermotility, menthofuran (50 and 100 mg/kg) reduced the number of loose stools as observed for the normal group. Additionally, menthofuran induced a marked concentration-dependent relaxation in rat ileum segments precontracted with KCl (EC50 = 0.059 ± 0.008 μg/mL) or carbachol (EC50 = 0.068 ± 0.007 μg/mL). These results suggest the possible decrease of calcium influx underlying the effects of menthofuran on the gastrointestinal tract, which opens the door for further study regarding this potential application for the treatment of gastrointestinal disorders, noting possible limitations of its use due to adverse effects in children.